HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunohistochemical and molecular genetics study of a granular cell astrocytoma: a case report of malignant transformation to a glioblastoma.

Abstract
We treated a 56-year-old woman who had a right temporal lobe tumor found by chance after a traffic accident. MRI confirmed a heterogeneously enhanced tumor in the temporal lobe with large peritumoral edema extending to the superior parietal lobe. The patient underwent tumor resection. The tumor consisted largely of distinct cells with discrete borders and granular cytoplasm. In granular cells, the accumulation of PAS-positive granules was observed. Immunohistochemical analysis demonstrated positive staining for GFAP, S-100, and oligodendrocyte transcription factor 2 and negative staining for synaptophysin. CD68 was negative in granular cells, but positive in stromal cells. Ki-67 labeling index was quite low. The tumor was diagnosed as a granular cell astrocytoma (GCA). Postoperative radiotherapy combined with temozolomide was administered. One month after chemoradiotherapy, the tumor occurred in the parietal lobe, and a tumorectomy was performed. The tumor was composed of poorly differentiated astrocytic tumor cells with prominent microvascular proliferation and necrosis. A small number of granular cells were locally observed and the tumor was diagnosed as a glioblastoma. O6-methylguanine-DNA methyltransferase promoter methylation was detected in the GCA but not in the glioblastoma. Isocitrate dehydrogenase mutations were not detected in either tumor. Comparative genomic hybridization analysis demonstrated that no chromosomal abnormality was found in the GCA; however, a gain of chromosomes 7 and 19 and a loss of chromosomes 10 and 9p21 (CDKN2A) were found in the glioblastoma. p53 was strongly expressed in both the GCA and glioblastoma. The tumor progressed despite extensive chemotherapy, and the patient died 1 year after the initial treatment. Our immunohistochemical, genetic and chromosomal analyses indicate that the glioblastoma was transformed from the GCA.
AuthorsTaiji Ishii, Katsu Mizukawa, Takashi Sasayama, Hikaru Sasaki, Saeko Hayashi, Satoshi Nakamizo, Hirotomo Tanaka, Kazuhiro Tanaka, Shigeo Hara, Chihoko Hirai, Tomoo Itoh, Eiji Kohmura
JournalNeuropathology : official journal of the Japanese Society of Neuropathology (Neuropathology) Vol. 33 Issue 3 Pg. 299-305 (Jun 2013) ISSN: 1440-1789 [Electronic] Australia
PMID22994265 (Publication Type: Case Reports, Journal Article)
Copyright© 2012 Japanese Society of Neuropathology.
Chemical References
  • Isocitrate Dehydrogenase
Topics
  • Accidents, Traffic
  • Adenocarcinoma (genetics, pathology, surgery)
  • Astrocytoma (genetics, pathology, surgery)
  • Brain Neoplasms (genetics, pathology, surgery)
  • Cell Transformation, Neoplastic (pathology)
  • Chemoradiotherapy
  • Combined Modality Therapy
  • Fatal Outcome
  • Female
  • Fluorescent Antibody Technique
  • Glioblastoma (genetics, pathology, surgery)
  • Humans
  • Immunohistochemistry
  • Isocitrate Dehydrogenase (genetics)
  • Magnetic Resonance Imaging
  • Middle Aged
  • Neurosurgical Procedures (methods)
  • Nucleic Acid Hybridization
  • Positron-Emission Tomography
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: